PRODRUGS OF THROMBIN INHIBITORS Russian patent published in 2001 - IPC

Abstract RU 2176644 C2

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes novel compounds of the general formula (I): R1-O(O)C-CH2-(R)Cgl-Aze-Pab-R2 where R1 means -R3 or -A1-C(O)N-(R4)R5 or -A1-C(O)O-R4; A1 means C1-5-alkylene; R2 (that replaces one of hydrogen atom in amidine unit in Pab-H) means OH, OC(O)-R6, C(O)O-R7 or C(O)OCH((R8))OC(O)-R9; R3 means H, C1-10-alkyl or C1-3-alkyl-phenyl (being the latter group is substituted possibly with C1-6-alkyl); R4 and R5 mean independently H, C1-6-alkyl or when R1 means -A1-C(O)N-(R4)R5 in common with nitrogen atom to which they are bound mean pyrrolidinyl group; R6 means C1-17-alkyl or phenyl; R7 means phenyl, C1-3-alkylphenyl (being two latter groups are substituted possibly with C1-6-alkyl, C1-6-alkoxy-group or nitro-group) or C1-12-alkyl (being the latter group is substituted possibly with C1-6-alkoxy-group or halogen atom); R8 means H or C1-4-alkyl and R9 means phenyl or C1-8-alkyl being alkyl groups that can be presented by R3,R4,R5,R6,R7 and R9 can be linear ones or in the case of sufficient amount of carbon atoms they can be branched, cyclic or partially cyclic, saturated or unsaturated ones and can be broken by oxygen atom under condition that when R1 means R3 then R3 means benzyl, methyl, ethyl, n-butyl or n-hexyl group and R2 means C(O)O-R7 and then R7 does not mean benzyl; or its pharmaceutically acceptable salt. New compounds relate to pharmaceutically useful prodrugs of pharmaceutically active compounds that are competitive inhibitors of trypsin-like serine proteases, especially, thrombin. EFFECT: new compounds indicated above, valuable medicinal properties. 66 cl, 1 tbl, 70 ex

Similar patents RU2176644C2

Title Year Author Number
NOVEL DERIVATIVES OF MANDELIC ACID AND THEIR USING AS THROMBIN INHIBITORS 2001
  • Ingkhardt Tord
  • Jokhansson Anders
  • Svensson Arne
RU2300521C2
PHARMACEUTICAL COMPOSITION 2002
  • Gaik-Lim Kkhoo Sintija
  • Gustafsson Khelena
RU2323006C2
ALMOND ACID DERIVATIVES AND THEIR USE AS THROMBIN INHIBITOR 2002
  • Ingkhardt Tor
  • Jokhansson Anders
  • Svensson Arne
RU2341516C2
PHARMACEUTICAL PREPARATION WITH MODIFIED ELUTION 2003
  • Magnusson Anders
  • Tune Mikaehl'
RU2352323C2
TIME-RELEASE PHARMACEUTICAL COMPOSITION AND USE THEREOF 2003
  • Magnusson Anders
  • Tune Mikaehl'
RU2474416C2
THROMBIN INHIBITORS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF TREATMENT, METHOD OF THEIR SYNTHESIS (VERSIONS) AND PROTECTED DERIVATIVE 1996
  • Gustafsson David
  • Njustrem Jan-Ehrik
RU2176645C2
PHARMACEUTICAL PREPARATION WITH IMMEDIATE RELEASE 2003
  • Abrakhmsen Alami Susanna
  • Ingkhardt Tord
  • Magnusson Anders
  • Sigfridsson Karl-Gustaf
  • Tune Mikaehl'
RU2351314C2
THROMBIN INHIBITOR-CONTAINING AQUEOUS SOLUTION FOR NONPARENTERAL ADMINISTRATION SHOWING STABILITY AT STORAGE 1995
  • Ulla St'Ernfel'T
  • Mats Sundgren
RU2164803C2
PEPTIDE DERIVATIVES, THEIR STEREOISOMERS OR PHYSIOLOGICALLY ACCEPTABLE SALTS SHOWING ANTITHROMBOSIS, ANTICOAGULATING OR ANTI-INFLAMMATORY ACTIVITY, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF SUPPRESSION OF THROMBIN ACTIVITY, METHOD OF INHIBITION OF KININOGENASES ACTIVITY, USE OF COMPOUNDS AS PARENT SUBSTANCES FOR SYNTHESIS OF THROMBIN INHIBITOR 1994
  • Karl Tomas Antonsson
  • Rut Ehl'Vju Bjulund
  • Nil'S David Gustafsson
  • Nil'S Olov Ingemar Nil'Sson
RU2142469C1
AZABICYCLOOCTANE DERIVATIVE, PHARMACEUTICAL PREPARATIONS, METHOD FOR PROPHYLAXIS OR TREATMENT, METHODS FOR PREPARING COMPOUNDS, COMPOUNDS 2000
  • B'Ersne Magnus
  • Ponten Frit'Of
  • Strandlund Jert
  • Svensson Peder
RU2262505C2

RU 2 176 644 C2

Authors

Antonsson Tomas

Gustafsson David

Khoffmann Kurt-Jurgen

Njustrem Jan-Ehrik

Serensen Khenrik

Sellen Mikaehl'

Dates

2001-12-10Published

1996-12-17Filed